The medicinal benefits of lentinan (β-1, 3-D glucan) from Lentinus edodes (Berk.) Singer (shiitake mushroom) through oral administration

International Journal of Medicinal Mushrooms

Volumn 7, Issue 1-2, 2005, Pages 175-191

  Yap, Ann Teck ^a   Ng, Mah Lee ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antitumor effect; B and T lymphocytes; Colon carcinoma; Cytokines; Immunodeficient mice; Immunomodulating effect; Lentinan; Lentinus edodes; Shiitake mushrooms

Indexed keywords

BETA GLUCAN; BUFFER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; LENTINAN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER INHIBITION; COLON CARCINOMA; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOMODULATION; LENTINUS EDODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; NUDE MOUSE; OPTIMAL DRUG DOSE; REVIEW; SCID MOUSE; SCORING SYSTEM;

LENTINULA EDODES; MUS MUSCULUS;

EID: 20844437597     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v7.i12.170     Document Type: Review

References (38)

1. Balkwill F. R. 1989. Tumor necrosis factor and lymphokies. In: Cytokines in Cancer Therapy. Callard R., Cantrell D., Feldman M., Friedman R., Gordon M., Gullick B. and Hogg N., eds., Oxford University Press, New York, Chap 3, pp. 54-87.
2. Chihara G., Maeda Y. Y., Hamuro J., Sasaki T., and Fukuoka F. 1969. Inhibition of mouse Sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature, 222, 687-688.
3. Chihara G., Hamuro J., Maeda Y. Y., Aral Y., and Fukuoka F. 1970a. Antitumor polysaccharide derived chemically from natural glucan (pachyman). Nature, 225, 943-944.
4. Chihara G., Hamuro J., Maeda Y. Y., Arai Y., and Fukuoka F. 1970b. Fractionation and purification of polysaccharides with marked anti-tumor activity, especially Lentinan, from Lentinus edodes (Berk.) Sing. Cancer Res, 30, 2776-2781.
5. Chihara G., Hamuro J., Maeda Y.Y., Shiio, T. Suga T., Takasuka N., and Sasaki T. 1987. Antitumor and metastasis-inhibitory activities of Lentinan as an immunomodulator: An overview. Cancer Detect Rev Suppl, 1, 423-443.
6. Cohen G. M. 1997. Caspases: the executioners of apoptosis. Biochemistry J, 326, 1-16.
7. Cohen P. J., Cohen P. A., Rosenberg S. A., and Mulé J. J. 1994. Murine epidermal Langerhans cells and spleenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol, 24, 315-319.
8. Edagawa Y., Smriga M., Nishiyama N., and Saito H. 2001. Systemic administration of lentinan, a branched β-glucan, enhances long-term potentiation in the rat dentate gyrus in vivo. Neurosci Lett, 314, 139-142.
9. Fields M. S. and Koeller M. J. 1993. Hormonal therapy. In: Clinical Oncology. Weiss R. Geoffrey, eds., Prentice Hall International, Englewood Cliffs, NJ, Chap 15, pp. 110-118.
10. Fraser A. and Evan G. 1996. A license to kill. Cell, 85, 781-784.
11. Ger E. 1997. Mushrooms: enjoying your medicine. Delaware Med J, 69, 149-151.
12. 3. J Med, 26(5-6), 193-207.
13. Hanaue H., Tokuda T., and Machimura T. 1989. Effects of oral Lentinan on T-cell subsets in peripheral venous blood. Clin Therapeut, 11(5), 614-622.
14. Irinoda K., Masihi K. N., Chihara G., Kaneoka Y., and Katori T. 1992. Stimulation of microbicidal host defense mechanisms against aerosol influenza virus infection by lentinan. Int J Immunopharm, 14(5-8), 971-977.
15. Kurashige S., Akusawa Y., and Endo F. 1997. Effects of Lentinus edodes, Grifola frondosa, and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-Butanolnitrosoamine. Immunopharmacol Immunotoxicol, 19(2), 175-183.
16. Ladanyi A., Timar J., and Lapis K. 1993. Effect of Lentinan on macrophage cytotoxicity against metastatic tumor cells. J Cancer Immunolog Immunotherapy, 36, 123-126.
17. Maeda Y. Y., Yonekawa H., and Chihara G. 1994. Application of Lentinan as cytokine inducer and host defense potentiator in immunotherapy of infectious diseases. In: Immunotherapy of Infections, Masihi K. N., ed., Marcel Dekker, New York Chap. 27, pp. 261-280.
18. Marcus P. 1983. Interferon induction by viruses: one molecule of dsRNA as the threshold for induction. Interferon, 115-180.
19. Matsuoka H., Seo Y., Wakasugi H., Saito T., and Tomoda H. 1997. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res, 17(4A), 2751-2755
20. Miyakoshi H. and Aoki T. 1984. Acting mechanisms of Lentinan in human. Augmentation of DNA synthesis and immunoglobulin production of peripheral mononuclear cells. J Immunopharmacol, 6, 365-371.
21. Mizuno T. 1995. Shiitake, Lentinus edodes: functional properties for medicinal and food purposes. Food Rev Int, 11(1), 111-128.
22. Mizuno T., Saiko H., Nishitoba T., and Kawagishi H. 1995. Anti-tumor active substances from mushrooms. Food Rev Int, 11(1), 23-61.
23. Mori K., Toyomasu T., Nanba H., and Kuroda H. 1987. Anti tumor activity of fruit bodies of edible mushrooms orally administered to mice. Mushr J Tropics, 7, 121-126.
24. Murata Y., Shimamura T., Tagami T., Takatsuki F., and Hamuro J. 2002. The skewing to Th1 induced by Lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular gluthione content. Int Immunopharmacol, 2(5), 673-689.
25. Nanba H., Mori K., and Toyomasu T. 1987. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharmacol Bull, 35(6), 2453-2458.
26. Nakano H., Namatame K., Nemoto H., Motohashi H., Nishiyama K., and Kumada K. 1999. A multi-institutional prospective study of Lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Hepato-Gastroenterology, 46, 2662-2668.
27. Nicholson D. W. and Thornberry N. A. 1997. Caspases: killer proteases. Trends Biochemic Sci, 22, 299-306.
28. O'Hara Y. 1980. Fate of Lentinan (antitumor polysaccharide) 1: Fate of Lentinan in mice, rats, and dogs. J Toxicol Sci Suppl, 5, 59-72.
29. Suzuki I., Tanaka H., Kinoshita A., Oikawa S., Osawa M., and Yadomae T. 1990. Effect of orally administered β-glucan on macrophage function in mice. Int J Immunopharmacol, 12(6), 675-684.
30. Takahashi M., Fujimoto S., Takei M, Ohno K., Endoh F., Masuda Y., Masuda Y., and Obata G. 1992. Two-color flow cytometric analysis of spleenic lymphocyte subpopulations in patients with gastric cancer. Surg Today, 22, 35-39.
31. Thornberry N. A. and Littlewood Y. 1998. Caspases: enemies within. Science, 281, 1312-1316.
32. Tochikura T. S., Nakashima H., Ohashi Y., and Yahamoto N. 1987a. Inhibition of replication and cytopathic effect of human immunodeficiency virus by the extract of culture medium of Lentinus edodes mycelia in vitro. First Symposium on AIDS. 21 December 1987. Pp. 1-6.
33. Tochikura T. S., Nakashima H., Kaneko Y., Kobayashi N., and Yamamoto N. 1987b. Suppression of human immunodeficiency virus replication by 3-azido-3-deoxythymidine in various human haematopoietic cell lines in vitro: augmentation by the effect of Lentinan. Japan J Cancer Res (Gann), 78, 578-583.
34. Wasser S. P. and Weis A. L. 1999. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushr, 1, 31-62.
35. Yap A. T. and Ng M. L. 2001. An improved method for the isolation of Lentinan from the edible and medicinal shiitake mushroom, Lentinus edodes (Berk.) Sing. (Agaricomycetideae). Int J Med Mushr, 3, 9-19.
36. Yap A. T. and Ng M. L. 2002. Inhibition of human colon carcinoma development by Lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med, 8(5), 581-589.
37. Yap A. T. and Ng M. L. 2003. Immunopotentiating properties of Lentinan (1→3)-β-D glucan extracted from culinary-medicinal shiitake mushroom Lentinus edodes (Berk) Singer (Agaricomycetideae). Int J Med Mushr, 5, 353-372.
38. Yoshino S., Tabata T., Hazama S., Iizuka N., Yamamoto K., Hirayama M., Tangoku A., and Oka M. 2000. Immunoregulatory effects of the antitumor polysaccharide Lentinan on Th1/Th2 balance in patients with digestive cancers. Anticanc Res, 20, 4707-4711.